back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-20 17:04 Tx date 2025-03-19 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
$1,513,533
+409,063 vol $3.70 each |
508,710 | |
| Filed 2025-03-20 17:03 Tx date 2025-03-19 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,513,533
+409,063 vol $3.70 each |
||
| Filed 2025-03-20 17:00 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-2,261,209 vol |
77,972 | |
| Filed 2025-03-20 16:56 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,889,768 vol |
99,647 | |
| Filed 2025-03-20 16:26 Tx date 2025-03-19 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,513,533
+409,063 vol $3.70 each |
508,710 | |
| Filed 2025-03-20 16:26 Tx date 2025-03-19 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,513,533
+409,063 vol $3.70 each |
||
| Filed 2024-04-02 10:18 Tx date 2024-01-31 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+2,339,181 vol |
2,339,181 | |
| Filed 2024-04-02 10:16 Tx date 2023-09-05 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-02 10:11 Tx date 2024-01-31 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$3,999,999
+2,105,263 vol $1.90 each |
2,989,415 | |
| Filed 2023-09-07 11:43 Tx date 2023-09-06 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$2,999,999
+668,449 vol $4.49 each |
884,152 | |
| Filed 2023-09-07 11:42 Tx date 2023-09-05 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
215,703 |